Why Bone Loss Accelerates With Aging The Gut–Bone Connection

The host and guests repeatedly emphasized that bone loss is asymptomatic until fracture. Current guidelines that begin screening at 65 miss the window of maximal bone loss. In the Bondia trial, 15% of early postmenopausal women already had undiagnosed osteoporosis. The host noted that she now screens much earlier and uses CTX as an adjunct blood marker to track bone breakdown. She described a 26-year-old male patient with osteopenia discovered incidentally, underscoring that bone health is not just a postmenopausal issue.

The host shared that she used CTX to identify severe bone loss in her young male patient and tracked its drop from an extremely high level to the 200s with dietary changes and Bondia. Mark confirmed that in the Bondia trial, individuals with elevated BMI and high body fat who responded to Bondia showed significantly reduced CTX at 12 months compared to placebo, aligning with the DEXA findings. CTX provides a window into the current rate of bone breakdown, while P1NP (formation) remained unchanged, indicating that Bondia works mainly by slowing resorption.

Mark explained that Bondia is not meant to be a life-long colonizer; it lingers for about a week after stopping, which the company views as a safety advantage. The product is derived from microbes isolated from squash and fermented pepper paste, and to get the equivalent dose by eating whole foods you'd need 1.2 pounds of fermented pepper paste and 3.5 tons of squash. The trial showed excellent safety, with no increase in adverse events compared to placebo, and a surprise benefit: severe GI symptoms like constipation and nausea dropped by two-thirds, suggesting a general gut health boost. The host's clinic has integrated it into protocols for bone loss patients and is excited by the broad anti-inflammatory potential.

Alicia Bella presented the key animal experiment: ovariectomized mice lose bone, but if the same surgery is performed in germ-free mice (no gut microbiome), bone loss is halted. This demonstrates that the microbiome is necessary for the bone loss signal. She connected this to the fact that 70% of immune cells are gut-associated and that osteoclastogenesis — the formation of bone-resorbing cells — uses the same inflammatory signals as macrophage maturation. Mark added that clinical guidelines currently recommend DEXA scans only in the mid-60s, by which point 80% of women already have osteopenia or osteoporosis. The implication is that an anti-inflammatory gut intervention, started earlier, could preserve bone without waiting for fracture or diagnosis.